一个分子更新和儿童低级结质瘤当前试验的审查
Sarah Al-Jilaihawi1, Stephen Lowis1
1Department of Paediatric Oncology, Bristol Royal Hospital for Children, Bristol, UK.
Pediatric neurosurgery
|August 21, 2023
概括
儿科低度结质瘤 (pLGGs) 需要新的治疗方法来持续控制和改善存活率. 分子分类和向疗法的进步,特别是RAS-mitogen-activated protein kinase (RAS/MAPK) 途径的进步,为这些儿童大脑瘤提供了新的希望.
科学领域:
- 儿科瘤学 儿科瘤学
- 神经瘤学神经瘤学
- 分子生物学分子生物学
背景情况:
- 儿科低度质瘤 (pLGGs) 是最常见的儿科脑瘤.
- 尽管预后一般良好,但pLGGs可能会导致显著的长期发病率.
- 了解PLGG分子生物学方面的最新进展为向治疗提供了潜力.
研究的目的:
- 总结一下pLGGs的最新分子分类.
- 审查当前的治疗策略,新药和正在进行的临床试验.
- 突出需要改进的治疗策略,减少毒性.
主要方法:
- 对PLGGs最新分子分类的审查.
- 分析当前的治疗策略,包括手术和化疗.
- 检查新药和向疗法,包括针对RAS-mitogen-activated protein kinase (RAS/MAPK) 途径的新药和向疗法.
- 包括最近和正在进行的临床研究的数据.
主要成果:
- 一个集成分子和组织学特征的多层分类系统已经为PLGGs发展.
- 手术和化疗仍然是主要的支柱,但许多瘤进展.
- 针对RAS/MAPK途径的向疗法显示出希望.
结论:
- 需要改进治疗策略,以平衡瘤控制和生存质量.
- 世卫组织最新的分类包括分子数据,以便更好地分层风险和考虑向治疗.
- 分子表征对于临床试验至关重要,结果的评估超出了放射学范围.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K


